Non invasive criteria of reperfusion after thrombolysis in acute myocardial infarction
pp 222-228
DOI:
https://doi.org/10.7775/rac.v59i4.3454Abstract
In order to examine the relation between non-invasive reperfusion criteria and angiographic patency of acute myocardial infarction related coronary artery and also with left ventricular function, 184 patients who under- went left heart catheterisation were analyzed. All of them received intravenous thrombolytic treatment within 6 hours from the onset of acute myocardial infarction. The following criteria were considered, just before the infusion and two hours later: a) summatory of ST segment elevation (ECG criterium); b) CK value (enzimatic criterium), and c) anginal pain measured in a 1 to 10 score (clinical criterium). A reduction of 50 % or more in ST segment elevation sum or in the pain score or a more than two-fold increase in CK value were considered as positive criteria. The association between two or more criteria was calIed "reperfusion syndrome". Each individual criterium showed good correlation with myòcardial infarction-related coronary artery patency, but reperfusion syndrome met the best combination of sensitivity, specificity and predictive value. A positive reperfusion syndrome implied in 86 % probability of a patent vessel and a negative reperfusion syndrome implied in 87 % probability of an occluded one. A positive ECG criterium and a positive reperfusion syndrome predicted a higher angiographic ejectionfrac- tion even in the subgroup of patients with patent acute myocardial infarction-related vessel. It is concluded than non-invasive criteria and specially reperfusion syndrome are simple and useful markers of coronary reperfusion related to thrombolytic treatment and they are also related to postmyocardial infarction left ventricular function state.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Argentine Journal of Cardiology

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.







